The Scientist

» reagents, culture and neuroscience

Most Recent

image: Capsule Reviews

Capsule Reviews

By | July 1, 2013

Denial, Probably Approximately Correct, Permanent Present Tense, and Against Their Will

0 Comments

image: Widening the Fertile Window

Widening the Fertile Window

By | July 1, 2013

Denial, Probably Approximately Correct, Permanent Present Tense, and Against Their Will

1 Comment

image: Opinion: On Living Longer

Opinion: On Living Longer

By | June 24, 2013

Denial, Probably Approximately Correct, Permanent Present Tense, and Against Their Will

2 Comments

image: The Art of Science

The Art of Science

By | June 21, 2013

Denial, Probably Approximately Correct, Permanent Present Tense, and Against Their Will

2 Comments

image: Week in Review, June 17–21

Week in Review, June 17–21

By | June 21, 2013

Denial, Probably Approximately Correct, Permanent Present Tense, and Against Their Will

0 Comments

image: The Human Brain in Exquisite Detail

The Human Brain in Exquisite Detail

By | June 20, 2013

Denial, Probably Approximately Correct, Permanent Present Tense, and Against Their Will

1 Comment

image: Opinion: Toxicants and the Brain

Opinion: Toxicants and the Brain

By | June 17, 2013

Denial, Probably Approximately Correct, Permanent Present Tense, and Against Their Will

1 Comment

image: Learning to Use Brain-Computer Interfaces

Learning to Use Brain-Computer Interfaces

By | June 10, 2013

Denial, Probably Approximately Correct, Permanent Present Tense, and Against Their Will

1 Comment

image: Opinion: Going International

Opinion: Going International

By and | June 10, 2013

Denial, Probably Approximately Correct, Permanent Present Tense, and Against Their Will

0 Comments

image: Opinion: The Dilemma of Diversity

Opinion: The Dilemma of Diversity

By | June 10, 2013

Denial, Probably Approximately Correct, Permanent Present Tense, and Against Their Will

3 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech